- Salvage Chemotherapy after Gemcitabine Failure in Patients with Advanced Pancreatic Cancer: Survival Benefit in Selected Patients
-
Lee JL, Kim YT
- KMID: 783035
- Korean J Gastroenterol.
- 2008 Jul;52(1):59-63.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase II Study of Combination Chemotherapy with Gemcitabine, 5-fluorouracil, and Cisplatin for Advanced Pancreatic Cancer
-
Choi SB, Lee HY, Yuh YJ, Kim SR
- KMID: 772776
- Korean J Gastroenterol.
- 2005 May;45(5):348-353.
BACKGROUND/AIMS: Gemcitabine has been the standard regimen for advanced pancreatic cancer, but the effect on the response rate and survival is still disappointing, leading to many trials of combination... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Factors in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine Chemotherapy: Clinical Characteristics of Long-term Survivors
-
An SG, Kim DU, Song GA, Jang AL
- KMID: 2160668
- Korean J Gastroenterol.
- 2014 Dec;64(6):356-363.
- doi: 10.4166/kjg.2014.64.6.356
BACKGROUND/AIMS: Gemcitabine-based chemotherapy has been used as a standard treatment in patients with unresectable pancreatic cancer. However, the clinical outcomes of this regimen are still unsatisfactory in prolonging survival. We... -
- CITED
-
- Close
- SHARE
-
- Close
